While therapies targeting IL6-like cytokines such as IL11, OSM and CNTF are at different stages of development for the treatment of a range of diseases [17], only the IL11R-targeted agent BMTP-11 is being developed for its potential use in cancer treatment. This evidence concerns the gene OSM and cancer.